IL130335A - Serum-derived factor inducing cell differentiation and medical uses thereof - Google Patents

Serum-derived factor inducing cell differentiation and medical uses thereof

Info

Publication number
IL130335A
IL130335A IL13033597A IL13033597A IL130335A IL 130335 A IL130335 A IL 130335A IL 13033597 A IL13033597 A IL 13033597A IL 13033597 A IL13033597 A IL 13033597A IL 130335 A IL130335 A IL 130335A
Authority
IL
Israel
Prior art keywords
sdf
cells
fraction
complex
acetonitrile
Prior art date
Application number
IL13033597A
Other languages
English (en)
Other versions
IL130335A0 (en
Original Assignee
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Med Res Service filed Critical Hadasit Med Res Service
Publication of IL130335A0 publication Critical patent/IL130335A0/xx
Publication of IL130335A publication Critical patent/IL130335A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL13033597A 1996-12-10 1997-12-01 Serum-derived factor inducing cell differentiation and medical uses thereof IL130335A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3264696P 1996-12-10 1996-12-10
PCT/IL1997/000395 WO1998025634A1 (fr) 1996-12-10 1997-12-01 Facteur de serum induisant la differenciation cellulaire et utilisations medicales de ce dernier

Publications (2)

Publication Number Publication Date
IL130335A0 IL130335A0 (en) 2000-06-01
IL130335A true IL130335A (en) 2004-09-27

Family

ID=21866054

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13033597A IL130335A (en) 1996-12-10 1997-12-01 Serum-derived factor inducing cell differentiation and medical uses thereof

Country Status (7)

Country Link
US (2) US6372262B1 (fr)
EP (1) EP0973530A4 (fr)
JP (2) JP2001505906A (fr)
AU (1) AU731937B2 (fr)
CA (1) CA2274469C (fr)
IL (1) IL130335A (fr)
WO (1) WO1998025634A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001505906A (ja) * 1996-12-10 2001-05-08 ハダジット メディカル リサーチ サービシズ アンド ディベラップメント カンパニー リミテッド 細胞の分化を誘導する血清由来因子およびその医薬的使用
US6962698B1 (en) 1998-02-17 2005-11-08 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
CA2344653A1 (fr) * 1998-09-29 2000-04-06 Gamida Cell Ltd. Procedes de regulation de la proliferation et de la differentiation de cellules souches et precurseurs
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
US20100125265A1 (en) * 2008-11-20 2010-05-20 Medtronic Vascular, Inc. Cell Delivery System to Induce Cell Growth and Angiogenesis
JP5872468B2 (ja) * 2009-07-24 2016-03-01 ロード アイランド ホスピタル アスパラギニル−β−ヒドロキシラーゼ発現腫瘍に対する樹状細胞ワクチン
US20150064273A1 (en) 2012-02-13 2015-03-05 Gamida-Cell Ltd. Mesenchymal Stem Cells Conditioned Medium and Methods of Generating and Using the Same
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US11085023B2 (en) 2015-11-16 2021-08-10 Kenichi Yamahara Bovine serum composition and method for culturing cells using said bovine serum composition as additive
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US466844A (en) * 1892-01-12 Salt-sprinkler for dough-cutting machines
GB1304697A (fr) * 1970-02-11 1973-01-24
US4335116A (en) * 1980-10-07 1982-06-15 University Patents, Inc. Mineral-containing therapeutic compositions
US5650147A (en) * 1981-09-08 1997-07-22 The Rockefeller University Methods of stimulating granulocyte-macrophage progenitor cells
US4952607A (en) * 1982-05-27 1990-08-28 International Copper Research Association, Inc. Copper complex for treating cancer
IL68218A (en) * 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
JPS60149529A (ja) * 1984-01-14 1985-08-07 Mitsuyuki Shimizu 白血病細胞に対する分化誘導因子の産生方法
US4666844A (en) 1984-09-07 1987-05-19 Sungene Technologies Corporation Process for regenerating cereals
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
US4935000A (en) * 1986-04-03 1990-06-19 East Carolina University Extracellular matrix induction method to produce pancreatic islet tissue
GB8615701D0 (en) * 1986-06-27 1986-08-06 Delta Biotechnology Ltd Stable gene integration vector
US5154931A (en) * 1986-10-22 1992-10-13 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) Growth-stimulating material derived from porcine bone therefor and a manufacturing process
US5073492A (en) * 1987-01-09 1991-12-17 The Johns Hopkins University Synergistic composition for endothelial cell growth
US4863747A (en) * 1987-10-22 1989-09-05 Pioneer Hi-Bred International Bacterial treatment to preserve hay quality by addition of microorganisms of the genus Bacillus
US4820531A (en) * 1987-10-22 1989-04-11 Pioneer Hi-Bred International Bacterial treatment to preserve hay quality by addition of microorganisms of the genus bacillus
US4932992A (en) * 1988-11-03 1990-06-12 Tennessee Valley Authority Dual purpose urease and nitrification inhibitors
US5385933A (en) * 1989-02-27 1995-01-31 The United States Of America As Represented By The Department Of Health And Human Services Method for the treatment of cancer by use of the copper complex of S-(methylthio)-DL-homocysteine or the L-enantiomorph thereof
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5136025A (en) * 1990-04-04 1992-08-04 California Biotechnology Inc. Method to purify basic fibroblast growth factor
US5635387A (en) * 1990-04-23 1997-06-03 Cellpro, Inc. Methods and device for culturing human hematopoietic cells and their precursors
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
US5071872A (en) * 1990-08-14 1991-12-10 The Ohio State University Research Foundation Method for improving interleukin-2 activity using aci-reductone compounds
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
DE69227179D1 (de) * 1992-03-27 1998-11-05 Chen Chung Ho Mittel für Gewebe zur Erhaltung der Lebensfähigkeit und biologische Funktionen in der Chirurgie und Lagerung
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
DE4240635C2 (de) * 1992-12-03 1997-07-10 Lothar Prof Dr Kanz Vermehrung hämatopoetischer Vorläuferzellen ex vivo sowieZusammensetzungen hämatopoetischer Wachstumsfaktoren
CA2115522A1 (fr) * 1993-02-12 1994-08-13 Takeda Pharmaceutical Company Limited Muteine hst-2, adn codant pour cette muteine et preparation en contenant
US5654186A (en) * 1993-02-26 1997-08-05 The Picower Institute For Medical Research Blood-borne mesenchymal cells
JP3559585B2 (ja) * 1993-06-03 2004-09-02 株式会社林原生物化学研究所 トレハロース遊離酵素とその製造方法並びに用途
WO1995005843A1 (fr) * 1993-08-25 1995-03-02 Systemix, Inc. Procede de production d'une population de cellules souches hematopoietiques fortement enrichie
US5426098A (en) * 1993-09-02 1995-06-20 Celtrix Pharmaceuticals, Inc. Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta
NZ250858A (en) * 1993-12-27 1995-08-28 Hayashibara Biochem Lab Alkali-treated bagasse, its fermentation and use as animal feed
TW323222B (fr) * 1993-12-27 1997-12-21 Hayashibara Biochem Lab
US5565491A (en) * 1994-01-31 1996-10-15 Bristol-Myers Squibb Company Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
US5489304A (en) * 1994-04-19 1996-02-06 Brigham & Women's Hospital Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft
US5666557A (en) * 1994-06-16 1997-09-09 Cassidy; Bruce Michael Method and apparatus for automatically assigning device identifiers on a parallel data bus
US5665557A (en) 1994-11-14 1997-09-09 Systemix, Inc. Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof
US5677136A (en) * 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
US5637323A (en) * 1994-11-16 1997-06-10 The United States Of America As Represented By The Department Of Health And Human Services Method of mobilizing pluripotential hematopoietic stem cells with IL-7
US5736396A (en) * 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5716616A (en) * 1995-03-28 1998-02-10 Thomas Jefferson University Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects
US5733541A (en) * 1995-04-21 1998-03-31 The Regent Of The University Of Michigan Hematopoietic cells: compositions and methods
US5925567A (en) * 1995-05-19 1999-07-20 T. Breeders, Inc. Selective expansion of target cell populations
US5674750A (en) * 1995-05-19 1997-10-07 T. Breeders Continuous selective clonogenic expansion of relatively undifferentiated cells
US5728581A (en) * 1995-06-07 1998-03-17 Systemix, Inc. Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
US5627070A (en) * 1995-07-26 1997-05-06 Celltherapy, Inc. Cell growing device for in vitro cell population expansion
JP2001505906A (ja) * 1996-12-10 2001-05-08 ハダジット メディカル リサーチ サービシズ アンド ディベラップメント カンパニー リミテッド 細胞の分化を誘導する血清由来因子およびその医薬的使用
EP1105463A1 (fr) 1998-08-24 2001-06-13 t. Breeders, Inc. Population de cellules contenant des hemangioblastes d'origine non foetale et leur procede de production

Also Published As

Publication number Publication date
AU5133198A (en) 1998-07-03
EP0973530A4 (fr) 2002-01-16
IL130335A0 (en) 2000-06-01
JP2001505906A (ja) 2001-05-08
AU731937B2 (en) 2001-04-05
US6783775B2 (en) 2004-08-31
CA2274469C (fr) 2009-09-01
CA2274469A1 (fr) 1998-06-18
US6372262B1 (en) 2002-04-16
EP0973530A1 (fr) 2000-01-26
WO1998025634A1 (fr) 1998-06-18
US20020054916A1 (en) 2002-05-09
JP2004196816A (ja) 2004-07-15

Similar Documents

Publication Publication Date Title
EP0691988B1 (fr) Inhibiteur de la proliferation de cellules souche et ses utilisations
Sachs The control of growth and differentiation in normal and leukemic blood cells
CA1296667C (fr) Procede de preparation de cellules k activees par des lymphokines
Rivoltini et al. In vitro anti‐tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5
WO1994022915A9 (fr) Inhibiteur de la proliferation de cellules souche et ses utilisations
FI117468B (fi) Kantasolujen lisääntymisen inhibiittoreita
Matousek et al. Immunosuppressive activity of angiogenin in comparison with bovine seminal ribonuclease and pancreatic ribonuclease
JPH07508714A (ja) 免疫療法に使用する低毒性のインターロイキン２類似体
IL130335A (en) Serum-derived factor inducing cell differentiation and medical uses thereof
US20210355445A1 (en) Kit containing medium for culturing natural killer cells and method of effectively culturing natural killer cells using the same
CN115558641B (zh) 高纯度效应免疫细胞群及其培养方法、试剂组合物和应用
EP0690125A2 (fr) Procédé de culture d'induction de lymphocytes T cytotoxiques capable de détruire des cellules tumorales
WO2024090703A1 (fr) Procédé de culture efficace pour la prolifération de cellules tueuses naturelles et son utilisation
KR100695677B1 (ko) 안티센스 조성물 및 암-치료 방법
Constine et al. Interleukin 1 alpha stimulates hemopoiesis but not tumor cell proliferation and protects mice from lethal total body irradiation
Cesano et al. Use of a lethally irradiated major histocompatibility complex nonrestricted cytotoxic T-cell line for effective purging of marrows containing lysis-sensitive or-resistant leukemic targets [see comments]
EP1150694B1 (fr) Composition cellulaire contenant des macrophages, presentant des proprietes antiseptiques et hematopoietiques et procede de preparation correspondant
Paul et al. Modulatory role of thymosin-alpha-1 in normal bone-marrow haematopoiesis and its effect on myelosuppression in T-cell lymphoma bearing mice
EP3909591B1 (fr) Composition pharmaceutique pour le traitement de la pancréatite, comprenant des cellules souches clonales
Mera et al. The Spleen Contributes Stem Cells to Peripheral Blood Stem Cell Transplants
EP2002840A2 (fr) Procede de traitement de maladies cancereuses
US20020037535A1 (en) Use of mCRP to slow cell growth and to promote maturation of cells
McNiece et al. The role of stem cell factor in the hematopoietic system
Agah et al. Lysosome rich cells contain the lytic activity of lymphokine-activated killer cell populations
JP2747355B2 (ja) ヒト血中単球増殖剤

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees